Mydecine Innovations Group Inc C.MYCO

Alternate Symbol(s): MYCOF

Healthcare Advertising Agencies

Mydecine Innovations Group Inc. is a Canada-based biotechnology company. The Company is engaged in developing medications and therapies to address mental health disorders, such as nicotine addiction and posttraumatic stress disorder (PTSD). The Company conducts research and development on second generation compounds in Canada with a focus on developing and commercializing psychedelic-inspired regulated medicines. The Company has two lead 3,4-Methylenedioxymethamphetamine (MDMA) candidates. The Company is channeling its MYCO-005, MYCO-006, and MYCO-007 families of patent-pending second-generation MDMA and Psilocybin analogs through Applied Pharmaceutical Innovation (API). It utilizes artificial intelligence (AI) and pharma research infrastructure at the University of Alberta to develop and manufacture new medications to make them accessible to the general public upon Health Canada and Food and Drug Administration (FDA) approval.

CSE:MYCO - Post by User

Mydecine Innovations Group Inc

Bullboard Posts

Comment by TonkaDogon Dec 27, 2017 9:40pm

228 Views

Post# 27235184

RE:RE:NF is selling their Washington facility

GobSmacked wrote:
No they have anonbinding letter with no deposit which is about as valuable as the plastic sheet now covering the greenhouse they built..I bet the deal never happens..I mean really no deposit..Nada nothing...

a LOI is a legally binding agreement about 2 steps removed from an agreement/contract. The LOI 'locks' in the sale agreement to prevent any other potential purchasers attempting to sway either party with a 'better deal'. Unless either parties' dd brings up a fundamental or fatal flaw in the offer, either party can pursue legal action to either satisfy the contract or seek compensation.

So the deal will usually go through about 95% guaranteed once a LOI is signed.

Bullboard Posts

Mullen Group's Robust Case for Value, Part 1: Less-than-Truckload